# Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis

**Authors:** Daniel Windschall, Tanja Hinze, Sven Hardt, Duygu Aydin, Faekah Gohar

PMC · DOI: 10.1093/rap/rkag017 · Rheumatology Advances in Practice · 2026-03-05

## Full-text entities

- **Diseases:** juvenile dermatomyositis (MESH:D003882)
- **Chemicals:** anifrolumab (MESH:C582345)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13006197/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13006197/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC13006197/full.md

---
Source: https://tomesphere.com/paper/PMC13006197